Literature DB >> 2221053

Insulin binding to individual rat skeletal muscles.

D J Koerker1, I R Sweet, D G Baskin.   

Abstract

Studies of insulin binding to skeletal muscle, performed using sarcolemmal membrane preparations or whole muscle incubations of mixed muscle or typical red (soleus, psoas) or white [extensor digitorum longus (EDL), gastrocnemius] muscle, have suggested that red muscle binds more insulin than white muscle. We have evaluated this hypothesis using cryostat sections of unfixed tissue to measure insulin binding in a broad range of skeletal muscles; many were of similar fiber-type profiles. Insulin binding per square millimeter of skeletal muscle slice was measured by autoradiography and computer-assisted densitometry. We found a 4.5-fold range in specific insulin tracer binding, with heart and predominantly slow-twitch oxidative muscles (SO) at the high end and the predominantly fast-twitch glycolytic (FG) muscles at the low end of the range. This pattern reflects insulin sensitivity. Evaluation of displacement curves for insulin binding yielded linear Scatchard plots. The dissociation constants varied over a ninefold range (0.26-2.06 nM). Binding capacity varied from 12.2 to 82.7 fmol/mm2. Neither binding parameter was correlated with fiber type or insulin sensitivity; e.g., among three muscles of similar fiber-type profile, the EDL had high numbers of low-affinity binding sites, whereas the quadriceps had low numbers of high-affinity sites. In summary, considerable heterogeneity in insulin binding was found among hindlimb muscles of the rat, which can be attributed to heterogeneity in binding affinities and the numbers of binding sites. It can be concluded that a given fiber type is not uniquely associated with a set of insulin binding parameters that result in high or low binding.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221053     DOI: 10.1152/ajpendo.1990.259.4.E517

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Insulin transport within skeletal muscle transverse tubule networks.

Authors:  P R Shorten; C D McMahon; T K Soboleva
Journal:  Biophys J       Date:  2007-07-13       Impact factor: 4.033

2.  Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats.

Authors:  Mathangi Gopalakrishnan; Sandra Suarez; Anthony J Hickey; Jogarao V S Gobburu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

3.  Influence of insulin and muscle fiber type in nepsilon-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus.

Authors:  LeAnn M Snow; Ladora V Thompson
Journal:  Pathobiology       Date:  2009-10-02       Impact factor: 4.342

4.  PGC-1α mRNA level and oxidative capacity of the plantaris muscle in rats with metabolic syndrome, hypertension, and type 2 diabetes.

Authors:  Fumiko Nagatomo; Hidemi Fujino; Hiroyo Kondo; Ning Gu; Isao Takeda; Noriaki Ishioka; Kinsuke Tsuda; Akihiko Ishihara
Journal:  Acta Histochem Cytochem       Date:  2011-04-21       Impact factor: 1.938

5.  Long-lasting effect of obesity on skeletal muscle transcriptome.

Authors:  Ilhem Messaoudi; Mithila Handu; Maham Rais; Suhas Sureshchandra; Byung S Park; Suzanne S Fei; Hollis Wright; Ashley E White; Ruhee Jain; Judy L Cameron; Kerri M Winters-Stone; Oleg Varlamov
Journal:  BMC Genomics       Date:  2017-05-25       Impact factor: 3.969

6.  Pharmacokinetic-pharmacodynamic modelling of the hypoglycaemic effect of pulsatile administration of human insulin in rats.

Authors:  Makoto Miyazaki; Mariko Hayata; Noriaki Samukawa; Kazunori Iwanaga; Junya Nagai
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

7.  Muscle-Specific Myosin Heavy Chain Shifts in Response to a Long-Term High Fat/High Sugar Diet and Resveratrol Treatment in Nonhuman Primates.

Authors:  Jon-Philippe K Hyatt; Lisa Nguyen; Allison E Hall; Ashley M Huber; Jessica C Kocan; Julie A Mattison; Rafael de Cabo; Jeannine R LaRocque; Robert J Talmadge
Journal:  Front Physiol       Date:  2016-03-02       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.